Jordi Clarimon
Overview
Explore the profile of Jordi Clarimon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
8099
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma Y, Farris C, Weber S, Schade S, Nguyen H, Perez-Soriano A, et al.
Lancet Neurol
. 2024 Nov;
23(12):1225-1237.
PMID: 39577923
Background: The pathological hallmarks of multiple system atrophy and Parkinson's disease are, respectively, misfolded-α-synuclein-laden glial cytoplasmic inclusions and Lewy bodies. CSF-soluble misfolded α-synuclein aggregates (seeds) are readily detected in people...
2.
Manzoni C, Kia D, Ferrari R, Leonenko G, Costa B, Saba V, et al.
Am J Hum Genet
. 2024 Jun;
111(7):1316-1329.
PMID: 38889728
Frontotemporal dementia (FTD) is the second most common cause of early-onset dementia after Alzheimer disease (AD). Efforts in the field mainly focus on familial forms of disease (fFTDs), while studies...
3.
Chia R, Ray A, Shah Z, Ding J, Ruffo P, Fujita M, et al.
Neuron
. 2024 May;
112(13):2142-2156.e5.
PMID: 38701790
Multiple system atrophy (MSA) is an adult-onset, sporadic synucleinopathy characterized by parkinsonism, cerebellar ataxia, and dysautonomia. The genetic architecture of MSA is poorly understood, and treatments are limited to supportive...
4.
Swift I, Rademakers R, Finch N, Baker M, Ghidoni R, Benussi L, et al.
Alzheimers Res Ther
. 2024 Mar;
16(1):66.
PMID: 38539243
Background: Pathogenic heterozygous mutations in the progranulin gene (GRN) are a key cause of frontotemporal dementia (FTD), leading to significantly reduced biofluid concentrations of the progranulin protein (PGRN). This has...
5.
Vollstedt E, Madoev H, Aasly A, Ahmad-Annuar A, Al-Mubarak B, Alcalay R, et al.
PLoS One
. 2023 Oct;
18(10):e0292180.
PMID: 37788254
Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder, currently affecting ~7 million people worldwide. PD is clinically and genetically heterogeneous, with at least 10% of all cases explained by a...
6.
Gasca-Salas C, Trompeta C, Lopez-Aguirre M, Rodriguez Rojas R, Clarimon J, Dols-Icardo O, et al.
J Neuroimaging
. 2023 Sep;
33(6):953-959.
PMID: 37726927
Background And Purpose: The microtubule-associated protein tau (MAPT) H1 homozygosity (H1/H1 haplotype) is a genetic risk factor for neurodegenerative diseases, such as Parkinson's disease (PD). MAPT H1 homozygosity has been...
7.
Guen Y, Luo G, Ambati A, Damotte V, Jansen I, Yu E, et al.
Proc Natl Acad Sci U S A
. 2023 Aug;
120(36):e2302720120.
PMID: 37643212
Across multiancestry groups, we analyzed Human Leukocyte Antigen (HLA) associations in over 176,000 individuals with Parkinson's disease (PD) and Alzheimer's disease (AD) versus controls. We demonstrate that the two diseases...
8.
Luo J, Thomassen J, Bellenguez C, Grenier-Boley B, de Rojas I, Castillo A, et al.
JAMA Netw Open
. 2023 May;
6(5):e2313734.
PMID: 37195665
Importance: An estimated 40% of dementia is potentially preventable by modifying 12 risk factors throughout the life course. However, robust evidence for most of these risk factors is lacking. Effective...
9.
Zhu N, Santos-Santos M, Illan-Gala I, Montal V, Estelles T, Barroeta I, et al.
Transl Neurodegener
. 2023 May;
12(1):21.
PMID: 37158972
No abstract available.
10.
Iulita M, Bejanin A, Vilaplana E, Carmona-Iragui M, Benejam B, Videla L, et al.
Brain Commun
. 2023 Apr;
5(2):fcad074.
PMID: 37056479
The study of sex differences in Alzheimer's disease is increasingly recognized as a key priority in research and clinical development. People with Down syndrome represent the largest population with a...